secwatch.observer — SEC 8-K summary
======================================

Issuer:     IONIS PHARMACEUTICALS INC (IONS)
CIK:        0000874015
Form:       8-K
Filed at:   2021-11-26T23:59:59+00:00
Accession:  0001140361-21-039510
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Peter Reikes resigns from Ionis board to join FDA, effective Nov 21, 2021
--------------------------------------------------------------------------------

- Peter N. Reikes resigned from the Board of Directors effective November 21, 2021.
- Resignation due to accepting a position with the U.S. Food and Drug Administration to avoid a perception of conflict of interest.
- No successor has been named to fill the vacancy on the Board.
- Company expressed gratitude for Reikes' advice and leadership as a Board member.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/874015/000114036121039510/0001140361-21-039510-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/874015/000114036121039510/brhc10031117_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-21-039510

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer